The Nrf2 activator tBHQ inhibits T cell activation of primary human CD4 T cells

Por Turley, Alexandra E., Zagorski, Joseph W., Rockwell, Cheryl E.
Publicado no Cytokine (2014)

Nrf2-Dependent and -Independent Effects of tert-Butylhydroquinone, CDDO-Im, and H(2)O(2) in Human Jurkat T Cells as Determined by CRISPR/Cas9 Gene Editing

Por Zagorski, Joseph W., Maser, Tyler P., Liby, Karen T., Rockwell, Cheryl E.
Publicado no J Pharmacol Exp Ther (2017)

Inhibition of early T cell cytokine production by arsenic trioxide occurs independently of Nrf2

Por VanDenBerg, Kelly R., Freeborn, Robert A., Liu, Sheng, Kennedy, Rebekah C., Zagorski, Joseph W., Rockwell, Cheryl E.
Publicado no PLoS One (2017)

The Nrf2 Activator, tBHQ, Differentially Affects Early Events Following Stimulation of Jurkat Cells

Por Zagorski, Joseph W., Turley, Alexandra E., Dover, Heather E., VanDenBerg, Kelly R., Compton, Jacob R., Rockwell, Cheryl E.
Publicado em 2013

Chronic low-level cadmium exposure in rats affects cytokine production by activated T cells

Por Turley, Alexandra E., Zagorski, Joseph W., Kennedy, Rebekah C., Freeborn, Robert A., Bursley, Jenna K., Edwards, Joshua R., Rockwell, Cheryl E.
Publicado no Toxicol Res (Camb) (2019)

Differential Effects of the Nrf2 Activators tBHQ and CDDO-Im on the Early Events of T Cell Activation

Por Zagorski, Joseph W., Turley, Alexandra E., Freeborn, Robert A, VanDenBerg, Kelly R., Dover, Heather E., Kardell, Brian R., Liby, Karen T., Rockwell, Cheryl E.
Publicado no Biochem Pharmacol (2017)